| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The lancet 396 (10258), 1223-1249, 2020 | 5347 | 2020 |
| 2020 International Society of Hypertension global hypertension practice guidelines T Unger, C Borghi, F Charchar, NA Khan, NR Poulter, D Prabhakaran, ... Hypertension 75 (6), 1334-1357, 2020 | 3747 | 2020 |
| Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study H Krum, M Schlaich, R Whitbourn, PA Sobotka, J Sadowski, K Bartus, ... The Lancet 373 (9671), 1275-1281, 2009 | 3139 | 2009 |
| Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial Symplicity HTN-2 Investigators The Lancet 376 (9756), 1903-1909, 2010 | 3127 | 2010 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 VL Feigin, BA Stark, CO Johnson, GA Roth, C Bisignano, GG Abady, ... The Lancet Neurology 20 (10), 795-820, 2021 | 2917 | 2021 |
| Renal sympathetic-nerve ablation for uncontrolled hypertension MP Schlaich, PA Sobotka, H Krum, E Lambert, MD Esler New England Journal of Medicine 361 (9), 932-934, 2009 | 1228 | 2009 |
| Stenting and medical therapy for atherosclerotic renal-artery stenosis CJ Cooper, TP Murphy, DE Cutlip, K Jamerson, W Henrich, DM Reid, ... New England Journal of Medicine 370 (1), 13-22, 2014 | 1062 | 2014 |
| Renin-angiotensin system and cardiovascular risk RE Schmieder, KF Hilgers, MP Schlaich, BMW Schmidt The Lancet 369 (9568), 1208-1219, 2007 | 874 | 2007 |
| Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study F Mahfoud, M Schlaich, I Kindermann, C Ukena, B Cremers, MC Brandt, ... Circulation 123 (18), 1940-1946, 2011 | 866 | 2011 |
| Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study H Krum, MP Schlaich, PA Sobotka, M Böhm, F Mahfoud, K Rocha-Singh, ... The Lancet 383 (9917), 622-629, 2014 | 781 | 2014 |
| Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation MP Schlaich, E Lambert, DM Kaye, Z Krozowski, DJ Campbell, G Lambert, ... Hypertension 43 (2), 169-175, 2004 | 772 | 2004 |
| Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy MP Schlaich, DM Kaye, E Lambert, M Sommerville, F Socratous, MD Esler Circulation 108 (5), 560-565, 2003 | 670 | 2003 |
| Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial MD Esler, H Krum, M Schlaich, RE Schmieder, M Böhm, PA Sobotka Circulation 126 (25), 2976-2982, 2012 | 611 | 2012 |
| Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension F Mahfoud, B Cremers, J Janker, B Link, O Vonend, C Ukena, D Linz, ... Hypertension 60 (2), 419-424, 2012 | 604 | 2012 |
| Sympathetic activation in chronic renal failure MP Schlaich, F Socratous, S Hennebry, N Eikelis, EA Lambert, ... Journal of the American Society of Nephrology 20 (5), 933-939, 2009 | 550 | 2009 |
| Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept MP Schlaich, PA Sobotka, H Krum, R Whitbourn, A Walton, MD Esler Hypertension 54 (6), 1195-1201, 2009 | 549 | 2009 |
| Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension F Mahfoud, C Ukena, RE Schmieder, B Cremers, LC Rump, O Vonend, ... Circulation 128 (2), 132-140, 2013 | 502 | 2013 |
| Renal denervation in moderate to severe CKD D Hering, F Mahfoud, AS Walton, H Krum, GW Lambert, EA Lambert, ... Journal of the American Society of Nephrology 23 (7), 1250-1257, 2012 | 459 | 2012 |
| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 432 | 2023 |
| Relevance of sympathetic nervous system activation in obesity and metabolic syndrome AA Thorp, MP Schlaich Journal of diabetes research 2015, 2015 | 430 | 2015 |
Murray EslerSenior Director Baker IDI Heart and Diabetes InstituteVerified email at bakeridi.edu.au
